Aaronson, S.A. Growth factors and cancer. Science
254, 1146–1153 (1991).
Duffy, M.J. The role of proteolytic enzymes in cancer invasion and metastasis. Clin. Exp. Metastasis.
10, 145–155 (1992).
Rosenberg, S.A. A New Era for Cancer Immunotherapy Based on the Genes that Encode Cancer Antigens. Immunity.
10, 281–287 (1999).
Westermarck, J. & Kähäri, V.M. Regulation of matrix metalloproteinase expression in tumor invasion. FASEB. J.
13, 781–792 (1999).
Roy, R., Yang, J. & Moses, M.A. Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer. J. Clin. Oncol.
27, 5287–5297 (2009).
Zucker, S. & Vacirca, J. Role of matrix metalloproteinases (MMPs) in colorectal cancer. Cancer. Metastasis. Rev.
23, 101–117 (2004).
Turpeenniemi-Hujanen, T. Gelatinases (MMP-2 and -9) and their natural inhibitors as prognostic indicators in solid cancers. Biochimie.
87, 287–297 (2005).
Moses, M.A., Wiederschain, D., Loughlin, K.R., Zurakowski, D. & Freeman, M.R. Increased Incidence of Matrix Metalloproteinases in Urine of Cancer Patients. Cancer. Res.
58, 1395–1399 (1998).
Angelina, D.C., Daniela, T., Angela, M. & Vincenzo, M. Urinary gelatinase activities (matrix metalloproteinases 2 and 9) in human bladder tumors. Oncol. Rep.
15, 1321–1326 (2006).
Angelina, D.C., Angela, M., Daniela, T. & Matteo, F. Matrix metalloproteinase-2 and -9 in the urine of prostate cancer patients. Oncol. Rep.
24, 3–8 (2010).
Coticchia, C.M., Curatolo, A.S., Zurakowski, D., Yang, J. & Daniels, K.E. Urinary MMP-2 and MMP-9 predict the presence of ovarian cancer in women with normal CA125 levels. Gynecol. Oncol.
123, 295–300 (2011).
Fitzsimmons, P.J. et al. Urinary levels of matrix metalloproteinase 9 and 2 and tissue inhibitor of matrix metalloproteinase in patients with coronary artery disease. J. Atheroscler. Res.
194, 196–203 (2007).
Kleber, C.J., Spiess, A., Kleber, J.B., Hinz, U. & Weiss, J. Urinary matrix metalloproteinases-2/9 in healthy infants and haemangioma patients prior to and during propranolol therapy. Eur. J. Pediatr.
71, 941–946 (2012).
Eissa, S. et al. Noninvasive Diagnosis of Bladder Cancer by Detection of Matrix Metalloproteinases (MMP-2 and MMP-9) and Their Inhibitor (TIMP-2) in Urine. Eur. Urol.
52, 1388–1397 (2007).
Wysocki, A.B., Staiano-Coico, L. & Grinnell, F. Wound Fluid from Chronic Leg Ulcers Contains Elevated Levels of Metalloproteinases MMP-2 and MMP-9. J. Invest. Dermatol.
101, 64–68 (1993).
Wang, C. et al. Expression and characterization of common carp (Cyprinus carpio) matrix metalloproteinase-2 and its activity against type I collagen. J. Biotechnol.
177, 45–52 (2014).
McQuibban, G.A., Butler, G.S., Gong, J.H. & Bendall, L. Matrix Metalloproteinase Activity Inactivates the CXC Chemokine Stromal Cell-derived Factor-1. J. Biol. Chem.
276, 43503–43508 (2001).
Yang, J. et al. Detection of MMP activity in living cells by a genetically encoded surface-displayed FRET sensor. BBA-Mol. Cell. Res.
1773, 400–407 (2007).
Wang, Y.H., Shen, P., Li, C.Y., Wang, Y.Y. & Liu, Z.H. Upconversion Fluorescence Resonance Energy Transfer Based Biosensor for Ultrasensitive Detection of Matrix Metalloproteinase-2 in Blood. Anal. Chem.
84, 1466–1473 (2012).
Kim, H.J., Yoon, H.K. & Yoo, T.H. Engineering b-lactamase zymogens for use in protease activity assays. Chem. Commun.
50, 10155–10157 (2014).
Han, Y.D., Chun, H.J. & Yoon, H.C. The transformation of common office supplies into a low-cost optical biosensing platform. Biosens. Bioelectron.
59, 259–268 (2014).
Carine, B., Catherine, M., Florence, M. & Sandrine, R. CENTA as a Chromogenic Substrate for Studying ß-Lactamases. Antimicrob. Agents Chemother.
45, 1868–1871 (2001).
Smith, E.R., Zurakowski, D., Saad, A. & Scott, R.M. Urinary Biomarkers Predict Brain Tumor Presence and Response to Therapy. Clin. Cancer. Res.
14, 2378–2386 (2008).
Roy, R. et al. Urinary TIMP-1 and MMP-2 levels detect the presence of pancreatic malignancies. Br. J. Cancer.
111, 1772–1779 (2014).
International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, ICH Harmonised Tripartite Guideline, Validation of analytical procedures: Text and Methodology Q2(R1) 2005.
Laraki, N., Franceschini, N., Roßsolini, G.M., Santucci, P. & Meunier, C. Biochemical Characterization of the Pseudomonas aeruginosa 101/1477 Metallo-Lactamase IMP-1 Produced by Escherichia coli. Antimicrob. Agents Chemother.
43, 902–906 (1999).